1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CELLECTIS - ADR
Cellectis - ADR
XNAS: CLLS
Weak Stock
Download real time
1.580.07(4.64%)
New 52W Low in past week
51,773.4
XNAS Volume
High vol.+loss this week

XNAS 22 Sep, 2026 12:17 PM (EDT)

Portfolio

Alert

My Notes

Cellectis (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Cellectis (ADR) share price target, revenues, EPS, net income and more

Cellectis (ADR) quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEGATIVE

    Quarterly Revenue Cellectis (ADR) Jun-2026 Quarterly Revenue is $5 Million which is growth of -68.7% YoY.

  • POSITIVE

    Quarterly Net Profit Cellectis (ADR) Jun-2026 Quarterly Net Profit is $-22 Million which is growth of 8.1% YoY.

Cellectis - ADR, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
5.25.810.435.216.710.712.716.28.14.50.30.20.2
Cost Of Rev.
2.42.332.42.422.52.81.52.41.81.91.3
Gross Profit
2.93.57.432.814.38.610.213.46.52.2-1.5-1.7-1.2
⌄
26.428.624.824.823.922.820.924.223.723.128.11922.5
Operating Profit
-23.5-25.2-17.48-9.6-14.2-10.7-10.8-17.2-20.9-29.6-20.7-23.7
⌄
-0.4-0.300.20.111.90.90.90.1-21.9-1.916
Profit Before Tax
-21.8-17.7-26.70.6-23.7-18.16.4-23.1-25.55.4-63.6-17.4-7.7
Tax
00.1-0.40.5-0.1-0.2-0.300.10.3
⌄
-21.8-17.8-26.30.6-23.7-18.15.9-23.1-25.35.6-42.9-17.5-10.7
Diluted NI Avail to Com Stockholders Ann.
-21.8-17.8-26.30.6-23.7-18.15.9-23.1-25.35.6-42.9-17.5-10.7
Basic EPS
-0.2-0.2-0.30-0.2-0.20.1-0.2-0.30.1-0.7-0.3-0.2
Diluted EPS After ExtraOrdinary
-0.2-0.2-0.20.1-0.1-0.1-0.1-0.1-0.2-0.1-0.9-0.4-0.1
Number Of Shares End
100.7100.5100.3100.3100.3100.2100.2100.189.971.865.455.656
Net Income Continuing Discontinued Operations
-21.8-17.8-26.30.6-23.7-18.15.9-23.1-25.35.6-42.9-17.5-10.7
Normalized Income
-23.5-23.5-178.3-9.5-13.2-8.1-9.8-16.2-14-52.5-21.4-5
Interest Income
1.61.82.12.32.22.93.632.81.91.50.732.3
Interest
21.922.12.11.91.91.91.81.81.61.516.3
Net Interest Income
-0.4-0.300.20.111.90.90.90.1-21.9-1.916
EBIT
-19.8-15.8-24.72.7-21.7-16.28.4-21.2-23.67.2-62.1-15.98.6
EBITDA
-15.4-11.3-19.67.7-16.7-11.314.2-16.5-18.911.7-56.9-11.413
Reconciled Cost Of Rev.
2.42.332.42.422.52.81.52.41.81.91.3
Reconciled Depr.
4.44.55.1554.95.84.74.74.65.24.54.4
Profit From Continuing Operations
-21.8-17.8-26.30.6-23.7-18.15.9-23.1-25.35.6-63.6-17.5-7.9
Normalized EBITDA
-17.5-19-10.215.4-2.4-6.3-1.1-3.2-9.7-14.4-44.8-16.613
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Cellectis (ADR) competitor comparison and performance snapshot within industry

Cellectis (ADR) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue Cellectis (ADR) Dec-2025 Annual Revenue is $73 Million which is growth of 75.8% YoY.

  • NEGATIVE

    Annual Net Profit Cellectis (ADR) Dec-2025 Annual Net Profit is $-68 Million which is growth of -83.9% YoY.

Cellectis - ADR, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
56.1%
-0.3%
 7341.50.819.257.37415.212.725.242.655
Cost Of Rev. Ann.
4.9%
-28.3%
109.89.27.48.545.851.611.41711.810.19.4
Gross Profit Ann.
80.8%
23.2%
46.563.232.3-6.710.711.522.33.8-4.313.432.545.7
Operating Exp. Ann.
-1.4%
-2.3%
104.596.291.990.6100.4142.2107.8127.4100.8106.196.476.2
Operating Profit Ann.
-
-
-58-33.1-59.6-97.3-89.7-130.7-85.4-123.6-105.1-92.7-64-30.5
⌄
-
-
-0.41.43.8-2.8-15-4.2-1.34.56.35.5-0.61.1
Other Exp. Ann.
-
-
 -36.319-16.46.19.7-10.73.810.5-16.60.67.1
PBT Ann.
-
-
-65.7-68-36.8-116.5-98.6-125.1-97.5-115.2-88.3-103.7-63.9-22.3
Tax Ann.
-
-
-0.4-0.40.40.1-
⌄
-
-
-65.3-67.6-36.8-101.1-106.1-114.2-81.1-102.1-78.7-99.4-63.9-22.5
Diluted NI Avail to Com Stockholders Ann.
-
-
-65.3-67.6-36.8-101.1-106.1-114.2-81.1-102.1-78.7-99.4-63.9-22.5
EPS Ann.
-
-
 -0.7-0.4-1.8-2.3-2.6-1.9-2.4-1.9-2.8-1.8-0.7
Diluted EPS Ann.
-
-
 -0.7-0.4-1.8-2.3-2.6-1.9-2.4-1.9-2.8-1.8-0.7
Number Of Shares End
30%
18.6%
 100.3100.265.445.745.542.842.542.43635.335.1
Total Exp. Ann.
-0.9%
-7.8%
 106101.198.1108.8188159.4138.7117.8117.8106.585.6
Net Income Continuing Discontinued Operations Ann.
-
-
-65.3-67.6-36.8-101.1-106.1-114.2-81.1-102.1-78.7-99.4-63.9-22.5
Normalized Income Ann.
-
-
-55.8-31.5-55.7-97.2-95.3-123.9-70.3-105.9-89.2-82.8-64.5-29.6
Interest Income Ann.
105.2%
36.6%
7.89.511.33.61.10.7276.821.61.1
Interest Ann.
28.7%
17.6%
8.18.17.55.33.85.33.62.60.100
EBITDA Ann.
-
-
-38.5-39.9-9.5-92.6-76.4-103.2-84.1-105.7-85.9-100.3-61.8-20.3
Reconciled Cost Of Rev. Ann.
4.9%
-26.6%
109.89.27.48.534.946.111.41711.810.19.4
Reconciled Depr. Ann.
3%
15.5%
19.120.119.918.518.416.69.86.92.43.42.11.9
Profit From Continuing Operations Ann.
-
-
-65.3-67.6-36.8-116.8-98.7-125.1-97.5-115.2-88.3-103.7-63.9-22.3
Normalized EBITDA Ann.
-
-
-31.3-3.5-28.4-76.3-82.4-112.9-73.3-109.5-96.4-83.8-62.4-27.5
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
75.9%
2Y CAGR
855.2%
3Y CAGR
56.1%
5Y CAGR
-0.3%
7Y CAGR
28.4%
10Y CAGR
2.9%
Total Revenue Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
4.7%
2Y CAGR
3%
3Y CAGR
-1.4%
5Y CAGR
-2.3%
7Y CAGR
-0.7%
10Y CAGR
2.4%
Operating Expenses Annual Cr growth is higher than historical averages.

Cellectis (ADR) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Cellectis (ADR) Dec-2025 Total Shareholders Fund is $76 Million which is growth of -42.1% YoY.

  • NEGATIVE

    Total Assets Cellectis (ADR) Dec-2025 Total Assets is $325 Million which is growth of -15.3% YoY.

Cellectis - ADR, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
7.5%
-7.1%
324.7383.5334.3261.2382.1469.5467.5500.8332.9330.7372.9
⌄
22.5%
9.1%
248.8252.5249.6135.3145.6160.611250.64756.684.7
⌄
-13.7%
-22.7%
75.913184.7118221.3275.6315.1409.3266.8272.2287.4
Total Capitalization Ann.
-1.1%
-15.8%
127.1175113.1131.5240.1299.8315.1409.3266.8272.2287.4
Tangible Assets Ann.
-13.7%
-22.7%
75.4129.984117.3219.4274314408265.5270.8286.4
Working Capital Ann.
3.9%
-19.2%
90.5120.877.980.8176.1263.1328.9440.8279.7255.7281.3
Invested Capital Ann.
-1.3%
-15.2%
131.2179.9118.3136.5242.3299.8315.1409.3266.8273.9289.4
Tangible Book Value Ann.
-13.7%
-22.7%
75.4129.984117.3219.4274314408265.5270.8286.4
Borrowings Ann.
6.2%
-3.2%
90.791.585.175.8100.9106.747.61.401.82.2
Net Debt Ann.
-
-
-----------
Share Issued Ann.
30%
18.6%
100.3100.171.845.745.542.842.542.43635.335.2
Number Of Shares End
30%
18.6%
100.3100.265.445.745.542.842.542.43635.335.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-15.3%
2Y CAGR
-1.4%
3Y CAGR
7.5%
5Y CAGR
-7.1%
7Y CAGR
-6%
10Y CAGR
-1.4%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-12.3%
2Y CAGR
-3%
3Y CAGR
32.3%
5Y CAGR
22.8%
7Y CAGR
17.6%
10Y CAGR
5.7%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-42.1%
2Y CAGR
-5.3%
3Y CAGR
-13.7%
5Y CAGR
-22.7%
7Y CAGR
-21.4%
10Y CAGR
-12.5%
Total ShareHolders Funds Annual is falling faster than historical averages.

Cellectis (ADR) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Cellectis (ADR) Book Value Per Share is $0 which is growth of -57.9% YoY.

  • NEUTRAL

    ROE Cellectis (ADR) ROE is 0% which is growth of 0% YoY.

Cellectis - ADR, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--10.24%-33.94%-33.00%-26.82%-17.31%-21.09%-18.88%-29.95%-18.17%-8.32%
ROE Ann. %
-
-
--34.08%-99.73%-62.57%-45.97%-27.45%-28.19%-23.28%-36.87%-22.84%-12.43%
ROIC %
-
-
-2-26-3.3-5.3-10.2-8.2-3.9-9.9-6.63.4
OPM Ann. %
-
-
-45.34%-143.48%-12,887.68%-467.72%-228.09%-115.54%-813.38%-825.47%-367.85%-150.20%-55.46%
Inventory Turnover Ratio Ann.
-
-
----5722.97.264.763.969.655.6
Asset Turnover Ann. %
-
-
-0.10.10.10.2000.10.10.2
Working Capital Turnover Ann.
58.7%
21.7%
0.80.300.20.30.30.100.10.20.2
Quick Ratio Ann.
-
-
-1.71.51.84.45.5610.17.25.44.3
Current Ratio Ann.
-
-
-1.71.52.34.666.310.47.45.64.3
Interest Coverage Ratio Ann.
-
-
--3.9-21-25-22.4-26.1-43.2-1,919.2-25,919.8-10,128.2-969.1
LT Debt To Equity Ann.
-
-
-0.60.80.50.40.40.2
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Cellectis (ADR) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Cellectis (ADR) Dec-2025 Cash From Operating Activity is $-39 Million which is growth of -271.4% YoY.

  • NEGATIVE

    Net Cash Flow Cellectis (ADR) Dec-2025 Net Cash Flow is $-86 Million which is growth of -1021.5% YoY.

Cellectis - ADR, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
-39.423-21.1-68.8-104.6-80.3-69.1-68.1-52.3-31.13.5
⌄
-
-
-29.5-102.8-15.6-2.37.3-54.3-35.935.61.8-50.5-7.6
⌄
-
-
-16.889.181.1-7.547.527.3-3.9236.541.30.5217.4
Cash Plus Cash Eqv. End Of Year Ann.
-12.9%
-23.9%
61.5143.3136.793.2185.6241.2340.5451.5256.4254343.6
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-85.79.342.6-89.1-49.8-107.3-108.9204-9.3-81.1213.3
Cash Plus Cash Eqv. Begin Of Year Ann.
-8.3%
-15.9%
143.3136.793.2185.6241.2340.5451.5256.4254.6330.5122.8
Income Tax Paid Supplemental Data Ann.
-
-
-----------
Interest Paid Supplemental Data Ann.
-
-
-----------
Capex Ann.
-
-
-3.5-3.8-1.1-2.4-19.7-46.3-13-4.9-2.7-13.3-4.4
Issuance Of Capital Stock Ann.
-
-
082.867.9-48.59.2236.641.30.7218
Issuance Of Debt Ann.
-
-
23.229.75.824.2----
Repayment Of Debt Ann.
-
-
-16.2-16.1-16.2-12.4-12.5-6.6-3.4-0.1-0-0.1-0.6
Repurchase Of Capital Stock Ann.
-
-
----0.6---0.5---0.1
Free Cash Flow Ann.
-
-
-42.919.2-25.8-89.9-124.3-126.5-82.1-73-55-44.4-0.8
*All financials are in USD Million and price data in USD
Add metric to table
Search...
×